Department of Molecular Genetics, Rabe Rashidi Institute, Tabriz, Iran.
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Division of Medical Genetics, Tabriz Children's Hospital, University of Medical Sciences, Tabriz, Iran.
Exp Mol Pathol. 2020 Jun;114:104399. doi: 10.1016/j.yexmp.2020.104399. Epub 2020 Feb 4.
Acute myeloid leukemia (AML) is a complex hematological neoplasm with poor prognosis. At present, overwhelming evidence indicates that different genetic abnormalities are relevant to the pathogenesis of AML. Nevertheless, its exact molecular mechanism is still unknown. Recently, it was reported that lncRNAs play crucial roles in tumorigenesis. But, their role in the molecular pathogenesis of AML has not been extensively explored. GAS5, one of the earliest known lncRNAs, has an essential role in the formation and progression of multiple human cancers. It was recently demonstrated that GAS5 acts as a riborepressor of the Glucocorticoid receptor) GR) and abnormal levels of GAS5 may alter response of hematopoietic cells to glucocorticoids. GAS5 can have interaction with the GR that encoded by NR3C1 gene and inhibit its transcriptional activity. To test whether the genetic variants can be associated with AML risk, we genotyped rs55829688 (T > C) polymorphism in GAS5 and three NR3C1 SNPs namely rs6195, rs41423247 and rs6189/rs6190 in a population of 100 Iranian AML patients and 100 healthy subjects. The analysis of the data showed the frequency of alleles and genotypes of rs55829688 and rs6189/rs6190 polymorphisms did not differ between patients and healthy subjects. But, rs41423247 and rs6195 demonstrated a significant correlation with AML risk. The rs6195 was associated with higher AML susceptibility in the co-dominant (OR = 4.58, 95% CI = 2.11-9.981, P < .0001), dominant (OR = 4.55, 95% CI = 2.155-9.613, P < .0001), and over-dominant (OR = 4.43, 95% CI = 2.042-9.621, P < .0001) models. Also, the rs41423247 polymorphism was associated with higher risk of AML in co-dominant (OR = 2.07, 95% CI = 1.171-4.242, P = .012) and dominant (OR = 2.47, 95% CI = 1.192-5.142, P = .010) models. Furthermore, haplotype analysis (rs41423247, rs6189.rs6190, rs6195, and rs55829688 respectively) demonstrated that GGAT, CGGT, and GGGT haplotypes were associated with higher risk of AML in the studied population (p-values = .007, 0.042 and 0.044, respectively). The present study reveals a possible role for NR3C1 in the pathogenesis of AML.
急性髓细胞白血病 (AML) 是一种预后不良的复杂血液系统恶性肿瘤。目前,大量证据表明,不同的遗传异常与 AML 的发病机制有关。然而,其确切的分子机制仍不清楚。最近,有报道称长链非编码 RNA (lncRNA) 在肿瘤发生中发挥着关键作用。但是,它们在 AML 分子发病机制中的作用尚未得到广泛探索。GAS5 是最早被发现的 lncRNA 之一,在多种人类癌症的发生和发展中具有重要作用。最近的研究表明,GAS5 作为糖皮质激素受体 (GR) 的核内核糖体抑制物发挥作用,异常的 GAS5 水平可能改变造血细胞对糖皮质激素的反应。GAS5 可以与 NR3C1 基因编码的 GR 相互作用,并抑制其转录活性。为了检验遗传变异是否与 AML 风险相关,我们对 100 例伊朗 AML 患者和 100 例健康对照者的 GAS5 基因 rs55829688(T>C) 多态性和 NR3C1 基因的三个 SNP(rs6195、rs41423247 和 rs6189/rs6190)进行了基因分型。数据分析显示,rs55829688 和 rs6189/rs6190 多态性的等位基因和基因型频率在患者和健康对照组之间无差异。但是,rs41423247 和 rs6195 与 AML 风险显著相关。rs6195 与 co-dominant (OR=4.58, 95% CI=2.11-9.981, P<.0001)、dominant (OR=4.55, 95% CI=2.155-9.613, P<.0001) 和 over-dominant (OR=4.43, 95% CI=2.042-9.621, P<.0001) 模型中的 AML 易感性升高相关。此外,rs41423247 多态性与 co-dominant (OR=2.07, 95% CI=1.171-4.242, P=0.012) 和 dominant (OR=2.47, 95% CI=1.192-5.142, P=0.010) 模型中的 AML 风险升高相关。此外,单体型分析(rs41423247、rs6189.rs6190、rs6195 和 rs55829688 分别)表明,在研究人群中,GGAT、CGGT 和 GGGT 单体型与 AML 风险升高相关(p 值分别为.007、0.042 和 0.044)。本研究提示 NR3C1 可能在 AML 的发病机制中起作用。